The global direct fed microbialsmarket size reached US$ 1.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1.8 Billion by 2028, exhibiting a growth rate (CAGR) of 6% during 2023-2028.
Direct-fed microbials (DFMs) are feed supplements that contain live and naturally occurring bacteria to improve the health and productivity of animals. They lower the pH, reduce enteric pathogens, and stimulate intestinal cell proliferation, which maintains the gut integrity of animals. They detoxify undesirable compounds, such as lactic acid and mycotoxins, to boost the immune system. They also help provide microbial balance in the digestive tract by producing high levels of beneficial enzymes, such as alpha amylase, cellulase, and protease. At present, there is a rise in the demand for DFMs due to the growing prevalence of different diseases among animals across the globe.
Direct Fed Microbials Market Trends:
The rising demand for poultry meat due to its high protein content, along with the growing livestock population around the world, represents one of the key factors driving the market. Besides this, the increasing awareness among the masses about the benefits of DFMs, such as enhancing metabolism, maintaining microbial flora in the intestine, ammonia production, and neutralizing enterotoxin, is offering lucrative growth opportunities to industry investors. Moreover, there is an increase in the replacement of antibiotic growth promoters with direct-fed microbials to reduce the risk of transmitting drug-resistant bacteria to humans. This, along with the burgeoning livestock industry, is contributing to the growth of the market. In addition, key market players are extensively investing in research and development (R&D) activities to introduce blockchain and the internet of things (IoT) technologies for managing the procurement, processing, and distribution of DFM products effectively. They are also focusing on various marketing strategies to expand their market reach. Apart from this, the rising utilization of DFMs to reduce the mortality rate of animals due to clostridial, diarrhea, and gastrointestinal diseases is bolstering the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global direct fed microbialsmarket report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, livestock and form.
Breakup by Product Type:
Lactic Acid Bacteria
Breakup by Livestock:
Breakup by Form:
Breakup by Region:
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being BASF SE, Alltech, American Biosystems Inc, Bayer AG, Bio-Vet, Cargill Incorporated, Chr. Hansen A/S (Chr Hansen Holding A/S), DuPont de Nemours Inc., Kemin Industries, Koninklijke DSM N.V., Lallemand Inc., Novozymes A/S (Novo Holdings A/S) and Novus International Inc. (Mitsui & Co. Ltd).
Base Year of the Analysis
Product Type, Livestock, Form, Region
Asia Pacific, Europe, North America, Latin America, Middle East and Africa
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
BASF SE, Alltech, American Biosystems Inc, Bayer AG, Bio-Vet, Cargill Incorporated, Chr. Hansen A/S (Chr Hansen Holding A/S), DuPont de Nemours Inc., Kemin Industries, Koninklijke DSM N.V., Lallemand Inc., Novozymes A/S (Novo Holdings A/S) and Novus International Inc. (Mitsui & Co. Ltd)
10% Free Customization
Report Price and Purchase Option
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report
The global direct fed microbials market was valued at US$ 1.3 Billion in 2022.
We expect the global direct fed microbials market to exhibit a CAGR of 6% during 2023-2028.
The rising demand for direct fed microbials as they aid in enhancing metabolism, maintaining microbial flora in the intestine, ammonia production, and neutralizing enterotoxin, is primarily driving the global direct fed microbials market.
The sudden outbreak of the COVID-19 pandemic had led to the implementation of stringent lockdown regulations across several nations, resulting in the temporary closure of numerous end-use industries for direct fed microbials.
Based on the product type, the global direct fed microbials market can be segmented into lactic acid bacteria, bacillus, and others. Currently, lactic acid bacteria holds the largest market share.
Based on the livestock, the global direct fed microbials market has been divided into swine, poultry, ruminants, aquatic animals, and others. Among these, poultry currently exhibits a clear dominance in the market.
Based on the form, the global direct fed microbials market can be categorized into dry and liquid. Currently, dry accounts for the majority of the global market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global direct fed microbials market include BASF SE, Alltech, American Biosystems Inc, Bayer AG, Bio-Vet, Cargill Incorporated, Chr. Hansen A/S (Chr Hansen Holding A/S), DuPont de Nemours Inc., Kemin Industries, Koninklijke DSM N.V., Lallemand Inc., Novozymes A/S (Novo Holdings A/S), and Novus International Inc. (Mitsui & Co. Ltd).
Need more help?
Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.